Advances in Clinical Management of Pulmonary Arterial Hypertension
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: 10 March 2025 | Viewed by 334
Special Issue Editor
2. Research Center, Montreal Heart Institute, Montreal, QC H1T 1C8, Canada
Interests: pulmonary hypertension; arrhythmia; atrial fibrillation; heart failure; aging; inflammation
Special Issue Information
Dear Colleagues,
Pulmonary arterial hypertension (PAH) is characterized by an abnormal and chronic increase in the mean pulmonary artery pressure. PAH has been associated with severe cardiac remodelling and life-threatening comorbidities. Although scientific knowledge has evolved throughout past decades, new strategies will be required to improve the management and quality of the life of PAH patients.
This Special Issue, titled Advances in Clinical Management of Pulmonary Arterial Hypertension, aims to highlight recent clinical and experimental discoveries regarding the mechanisms of PAH and the potential translational applications that could lead to developments of new treatment approaches, thus improving the diagnosis and clinical management of PAH.
In this Special Issue, we welcome original research articles and reviews. Research areas may include (but are not limited to) the following: pulmonary arterial hypertension, inflammation, resolution, cardiopulmonary disorders, and new therapeutic strategies in PAH management.
I look forward to receiving your contributions.
Sincerely,
Dr. Roddy Hiram
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary arterial hypertension
- lung inflammation
- cardiopulmonary disorders
- chronic hypoxia
- vasoconstriction
- vasorelaxation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
